10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,716,932 | +96.5% | 235,562 | +166.0% | 0.01% | +150.0% |
| Q2 2023 | $4,944,855 | +39471.5% | 88,554 | -60.5% | 0.00% | -71.4% |
| Q1 2023 | $12,496 | -71.7% | 223,981 | -81.5% | 0.01% | -70.8% |
| Q4 2022 | $44,216 | -99.3% | 1,213,394 | +467.3% | 0.02% | +500.0% |
| Q3 2022 | $6,092,000 | +54.5% | 213,907 | +145.5% | 0.00% | +100.0% |
| Q2 2022 | $3,942,000 | -73.3% | 87,116 | -55.2% | 0.00% | -75.0% |
| Q1 2022 | $14,782,000 | +41.0% | 194,316 | +176.0% | 0.01% | +60.0% |
| Q4 2021 | $10,487,000 | -63.1% | 70,402 | -55.1% | 0.01% | -75.0% |
| Q1 2021 | $28,394,000 | -40.9% | 156,873 | -53.8% | 0.02% | -42.9% |
| Q4 2020 | $48,068,000 | +611.0% | 339,463 | +526.0% | 0.04% | +337.5% |
| Q3 2020 | $6,761,000 | +19.4% | 54,225 | -40.3% | 0.01% | -38.5% |
| Q1 2020 | $5,664,000 | +196.1% | 90,888 | +262.3% | 0.01% | +550.0% |
| Q4 2019 | $1,913,000 | -21.7% | 25,086 | -48.3% | 0.00% | -50.0% |
| Q3 2019 | $2,444,000 | – | 48,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |